Resmed (RSMDF) Other Non-Current Liabilities (2010 - 2026)

Resmed has reported Other Non-Current Liabilities for 17 years, with the latest figure at $146.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 198.22% year-over-year to $146.1 million; the trailing twelve-month figure through Mar 2026 stood at $146.1 million (up 198.22% YoY), and the FY2025 full-year result was $141.5 million, up 234.9% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $146.1 million, up from $138.5 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $146.1 million in Q1 2026, with the low at $5.8 million in Q3 2022.
• Historically, Other Non-Current Liabilities has averaged $65.0 million across 5 years, with a median of $49.0 million in 2025.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities plunged 89.04% — and 2025, when it jumped 1179.09%.
• Resmed's Other Non-Current Liabilities stood at $37.2 million in 2022, then plunged by 67.3% to $12.2 million in 2023, then fell by 10.91% to $10.8 million in 2024, then jumped by 1179.09% to $138.5 million in 2025, then rose by 5.44% to $146.1 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $146.1 million (Q1 2026), $138.5 million (Q4 2025), and $138.2 million (Q3 2025), per Business Quant data.